Abstract
Introduction

63
Menopause, an expected event in a woman's life, is commonly defined as a 12-month 64 period of amenorrhea [1] or hypoestrogenism (estrogen level < 25 pg/mL) due to ovarian 65 senescence; therefore, the postmenopausal period may be considered the beginning of the aging 66 process in women. Postmenopausal aging is produced by a series of endocrinological changes 67 that lead to the erratic production of estrogens (mainly estradiol) that eventually bring to low transition [1] .
75
The marked reduction in E2 has been shown to increase levels of oxidative stress (OS) in 76 the body because E2 presents antioxidant properties due to its structure and its capacity to prevent
77
OS by different ways, such as free-radical scavenger, neutralizing excess reactive oxygen species 78 (ROS), and increasing antioxidant molecules (e.g. thioredoxin and superoxide dismutase) [5, 6] ; 79 therefore, E2 is part of the antioxidant system that counteracts OS during reproductive stage.
80
Additionally, low concentrations of this hormone have pro-oxidant like effects [7] . In this regard, 4 81 our research group have described that menopause is a risk factor for OS [8] because when the 82 production of E2 decreases, the antioxidant protection is lost and therefore OS increases.
83
Oxidative stress is also involved in the pathogenesis of menopausal symptoms, such as 84 vasomotor disturbances (e.g. HFs or night sweats). During menopause transition and 85 postmenopausal period, the women suffer repeated episodes of such vasomotor disturbances, 86 which produce an increase of the metabolic rate. These episodes of vasomotor symptoms 87 contribute to OS production by raising the level of oxidant species and by blocking antioxidants 88 and their function in neutralizing reactive oxygen/nitrogen species [7] .
89
Additionally, the relationship between HFs and OS is little understood; several studies 90 support an association, but others do not. Recently a report noted that HFs and OS are 91 independent events [9] , causing a controversy; therefore, the aim of this study was to assess the 92 association between HFs severity and OS in in Mexican postmenopausal women.
93
Material and methods
94
Study design and population 95 We carried out a cross-sectional study with a deterministic sample of 315 perimenopausal women 161 women were excluded due to different reasons (Fig 1) . Women included were separated into 102 two groups, a) 145 premenopausal women (yet with menstrual bleeding), and b) 170 103 postmenopausal women (without menses). All women were free of overt cardiovascular, kidney, 
116
We measured E2 level using a radioimmunoassay method (Siemens, Malvern, PA, USA)
117
and FSH level using a chemiluminescence method (Siemens). The within-run precision level for 118 these methods were 3.1% and 7.4%, respectively, and the E2 analytical sensitivity was 8 pg/mL.
119
Blood samples were collected after a 12-h fasting period by venipuncture and placed in 120 vacutainer/siliconized test tubes containing a separating gel and no additives, and heparin as Basilea, Sw). The intra-and inter-assay variation coefficients were less 5% in all determinations. The technicians were supervised to avoid possible biases in measurement.
139
Assessment of oxidative stress
140
With the blood samples containing heparin, we measured red blood cell superoxide 141 dismutase (SOD) and glutathione peroxidase (GPx) activities, plasma total antioxidant status 142 (TAS), and plasma malondialdehyde level (MDA). All the methods were validated in our 143 research laboratory, and the within-run precision for the markers were as follows: 3.8%, 4.6%, For depressive mood, we used the Zung Self-Rating Depression Scale (SDS) that consists 
Statistical analysis
204
Quantitative results were described with the means ± standard error (SE), and they were 205 compared using two sample t-test. We separated the women in three subgroups for each group 206 per the HFs intensity: 1) no/mild (< 2), 2) moderate (= 2), and 3) severe/very severe (≥ 3), and we 207 compared with one-way ANOVA with Dunnett test as posthoc, using subgroup 1 as control.
208
Categorical data were analyzed using frequencies, percentages and 95% confidence interval 209 (95%CI) for proportions, which were compared using the chi square test. Also, we calculated premenopausal women, the index did not change (Table 2) . (Table 4) . Accordingly, we observed a gradual increment of risk for OS in but is unable to establish a causal conclusion, and the sample size. Even so, the sample size that 387 allowed us to achieve similar subgroups size when we stratified by HFs severity in 388 postmenopausal women, the use of an integral OS index and the control of potential confounders 389 in the multivariate logistic models, are aspects that strengthen the study.
390
In conclusion, among Mexican postmenopausal women there is an association between
391
HFs severity and OS; however, longitudinal studies or controlled clinical trials must be carried 392 out to confirm our findings. 
